GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelira Therapeutics Ltd (ASX:ZLD) » Definitions » Credit Losses Provision

Zelira Therapeutics (ASX:ZLD) Credit Losses Provision


View and export this data going back to 2003. Start your Free Trial

What is Zelira Therapeutics Credit Losses Provision?

Credit Losses Provision only applies to banks.


Zelira Therapeutics (ASX:ZLD) Business Description

Traded in Other Exchanges
Address
101 St George’s Terrace, Level 3, Perth, WA, AUS, 6000
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.